USPTO serial 79210015
EVERION
Reviewed by CopyMark Law Group
Reg. 5790099Status 709
- Filing date
- Status date
- Registration date
- Jul 2, 2019
- Examiner
- CROWDER-SCHAEFER, ANDREW W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EVERION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Non-medical measuring apparatus, devices and instruments, namely, wearable activity trackers, computers, computer peripherals, wearable computer and wearable computer peripherals primarily for measuring, monitoring and tracking of activity, energy expenditure and steps, and also including measuring, monitoring and tracking of physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts to abnormal levels and rates and changes in levels and rates; Measuring apparatus, devices and instruments, namely, wearable activity trackers, computers, computer peripherals, wearable computers, and wearable computer peripherals for measuring, monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure; Downloadable computer programs for measuring, monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts to abnormal levels and changes in levels; Downloadable computer programs for measuring, monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts to abnormal levels and rates and changes in levels and rates; Downloadable computer programs for measuring, monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure; Computer software for measuring, monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts to abnormal levels and changes in levels; computer software for measuring, monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts to abnormal levels and rates and changes in levels and rates; computer software for measuring, monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure and providing alerts to changes in barometric pressure; Computer software, namely, data processing programs to process barometric pressure, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity data | SECTION 71 - CANCELLED | — |
| 010 | Medical measuring apparatus, devices and instruments for monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts to abnormal levels and significant changes in levels; Non-invasive medical devices for monitoring blood properties, and providing alerts to abnormal levels and changes in levels; Medical devices, namely, hemoglobin and oxygen saturation monitoring and analysis apparatus, and providing alerts to abnormal levels and changes in levels; Medical apparatus for monitoring blood perfusion index; pulse rate monitors; medical devices for monitoring, measuring, and analyzing blood coagulation, blood pressure and other blood properties, and providing alerts of abnormal levels and rates and changes in levels and rates; Medical measuring apparatus, devices and instruments for monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts of abnormal levels and rates and changes in levels and rates; Medical measuring apparatus, devices and instruments for monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure; Medical measuring apparatus, devices and instruments, namely, wearable digital electronic devices for monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts of abnormal levels and rates and changes in levels in rates; Medical measuring apparatus, devices and instruments, namely, wearable digital electronic devices for monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts of abnormal levels and rates and changes in levels and rates; Medical measuring apparatus, devices and instruments, namely, wearable digital electronic devices for monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure | SECTION 71 - CANCELLED | — |
| 035 | Business management and business strategy consulting; cost price analysis; commercial administration of the licensing of the goods and services of others; compilation, collection, analysis and systematization of data in computer databases, namely, business data compilation and database management in the field of medical health, physiological health, and bio-chemical health; data processing services of data in computer databases in the field of healthcare; business strategy consultancy services relating to the data processing in the field of medical health, physiological health, and bio-chemical health; computer file management, namely, management and compilation of computerized databases in the field of medical health, physiological health, and bio-chemical health; computer file management, namely, management and compilation of computerized databases; computerized database management in the field of medical health, physiological health, and bio-chemical health; computer file management, namely, management and compilation of computerized databases; data processing services for others; computerized data processing services | SECTION 71 - CANCELLED | — |
| 038 | Provision of access to global and local computer networks; provision of access to computer databases; transmission of data from computer databases via telecommunications networks and Internet | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services as well as research and design relating thereto, namely, blood analysis services in the nature of the monitoring, tracking, collection and assessment of blood chemistry, glucose levels and electrolyte levels, blood properties, blood perfusion index, pulse rate, blood coagulation, blood pressure, activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, information; industrial research and analysis services, namely, industrial research, scientific research, conducting engineering surveys, in the fields of medical and nonmedical technology to monitor, track and report blood chemistry, glucose levels and electrolyte levels, blood properties, blood perfusion index, pulse rate, blood coagulation, blood pressure, activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, information; technical project study, namely, studies in the field of scientific research; development of experimental and clinical testing strategies, namely, testing strategies, testing specifications and procedures for scientific research and clinical trials of medical products and medical technology; research and development services related to new products for others in the field of measuring apparatus, devices and instruments; design and development of computer software; writing of computer programs for data processing; technical advice in the field of science relating to in vivo physiological monitoring; development and programming of data processing computer programs; development of data processing systems, namely, computer programs; Computer software development and computer programming development for others, namely, development and programming of data processing programs; development of data processing systems, namely, data processing programs for third parties | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOSIGNS PTE LTD
- Other trademarks owned by BIOFOURMIS AG
- Other trademarks owned by Biovotion AG
- Other trademarks owned by Biovotion AG
- Other trademarks owned by Biovotion AG
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named EVERION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 16, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 16, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jul 2, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 11, 2020 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 27, 2020 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 15, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 26, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 26, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 2, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 2, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 31, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 30, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 12, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 11, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 11, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 11, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 11, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 11, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 7, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 21, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 21, 2018 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 14, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 14, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 14, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 7, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 25, 2018 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 25, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 25, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 25, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 5, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 4, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 28, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 6, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 5, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 28, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 27, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 19, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 19, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |